• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对富含癌症干细胞样和上皮-间质转化型特征的顺铂耐药口腔鳞状细胞癌细胞系进行微小RNA分析。

MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features.

作者信息

Ghosh Ruma Dey, Ghuwalewala Sangeeta, Das Pijush, Mandloi Sapan, Alam Sk Kayum, Chakraborty Jayanta, Sarkar Sajal, Chakrabarti Saikat, Panda Chinmoy Kumar, Roychoudhury Susanta

机构信息

Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.

Structural Biology and Bio-Informatics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.

出版信息

Sci Rep. 2016 Apr 5;6:23932. doi: 10.1038/srep23932.

DOI:10.1038/srep23932
PMID:27045798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4820705/
Abstract

Oral cancer is of major public health problem in India. Current investigation was aimed to identify the specific deregulated miRNAs which are responsible for development of resistance phenotype through regulating their resistance related target gene expression in oral squamous cell carcinoma (OSCC). Cisplatin-resistant OSCC cell lines were developed from their parental human OSCC cell lines and subsequently characterised. The resistant cells exhibited enhanced proliferative, clonogenic capacity with significant up-regulation of P-glycoprotein (ABCB1), c-Myc, survivin, β-catenin and a putative cancer-stem-like signature with increased expression of CD44, whereas the loss of E-cadherin signifies induced EMT phenotype. A comparative analysis of miRNA expression profiling in parental and cisplatin-resistant OSCC cell lines for a selected sets (deregulated miRNAs in head and neck cancer) revealed resistance specific signature. Moreover, we observed similar expression pattern for these resistance specific signature miRNAs in neoadjuvant chemotherapy treated and recurrent tumours compared to those with newly diagnosed primary tumours in patients with OSCC. All these results revealed that these miRNAs play an important role in the development of cisplatin-resistance mainly through modulating cancer stem-cell-like and EMT-type properties in OSCC.

摘要

口腔癌是印度主要的公共卫生问题。当前的研究旨在鉴定特定失调的微小RNA(miRNA),这些miRNA通过调节口腔鳞状细胞癌(OSCC)中与耐药相关的靶基因表达,从而导致耐药表型的产生。顺铂耐药的OSCC细胞系从其亲本人类OSCC细胞系中构建出来,随后进行表征。耐药细胞表现出增殖能力和克隆形成能力增强,P-糖蛋白(ABCB1)、c-Myc、生存素、β-连环蛋白显著上调,并且具有假定的癌症干细胞样特征,CD44表达增加,而E-钙黏蛋白的缺失表明诱导了上皮-间质转化(EMT)表型。对亲本和顺铂耐药的OSCC细胞系中miRNA表达谱进行比较分析(针对一组选定的miRNA,即头颈癌中失调的miRNA),揭示了耐药特异性特征。此外,我们观察到,与OSCC患者新诊断的原发性肿瘤相比,在接受新辅助化疗治疗的肿瘤和复发性肿瘤中,这些耐药特异性特征miRNA具有相似的表达模式。所有这些结果表明,这些miRNA主要通过调节OSCC中癌症干细胞样特性和EMT类型特性,在顺铂耐药的发生中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/fa599bbba4f8/srep23932-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/fa0b021b7cc9/srep23932-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/035bf71a2b16/srep23932-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/6eb5f6795495/srep23932-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/ca96eab84c64/srep23932-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/8b851d2c3a34/srep23932-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/5d0ef8651519/srep23932-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/eed22074cc24/srep23932-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/fa599bbba4f8/srep23932-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/fa0b021b7cc9/srep23932-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/035bf71a2b16/srep23932-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/6eb5f6795495/srep23932-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/ca96eab84c64/srep23932-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/8b851d2c3a34/srep23932-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/5d0ef8651519/srep23932-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/eed22074cc24/srep23932-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8461/4820705/fa599bbba4f8/srep23932-f8.jpg

相似文献

1
MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features.对富含癌症干细胞样和上皮-间质转化型特征的顺铂耐药口腔鳞状细胞癌细胞系进行微小RNA分析。
Sci Rep. 2016 Apr 5;6:23932. doi: 10.1038/srep23932.
2
The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.抗蠕虫药尼氯硝唑通过核β-连环蛋白/c-Myc 轴失调抑制口腔鳞状细胞癌中的癌症干性、细胞外基质重塑和转移。
Sci Rep. 2018 Aug 24;8(1):12776. doi: 10.1038/s41598-018-30692-3.
3
CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.CD44(高表达)CD24(低表达)分子特征决定口腔鳞状细胞癌中的癌症干细胞和上皮-间质转化表型。
Stem Cell Res. 2016 Mar;16(2):405-17. doi: 10.1016/j.scr.2016.02.028. Epub 2016 Feb 13.
4
MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.微小 RNA-485-5p 通过整合素/FAK/Src/ERK/β-连环蛋白通路靶向角蛋白 17 调节口腔癌干性和化疗耐药性。
J Biomed Sci. 2022 Jun 15;29(1):42. doi: 10.1186/s12929-022-00824-z.
5
Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.miR-204的抑制使口腔鳞状细胞癌能够促进癌症干性、上皮-间质转化特征和淋巴结转移。
Oncotarget. 2016 Apr 12;7(15):20180-92. doi: 10.18632/oncotarget.7745.
6
ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.ADAR1 通过促进致癌 miRNA 的成熟促进口腔癌细胞的上皮-间充质转化和干细胞样细胞表型。
J Exp Clin Cancer Res. 2019 Jul 17;38(1):315. doi: 10.1186/s13046-019-1300-2.
7
SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.SOX8 通过作用于 Wnt/β-catenin 通路调节舌鳞状细胞癌中的癌症干细胞样特性和顺铂诱导的 EMT。
Int J Cancer. 2018 Mar 15;142(6):1252-1265. doi: 10.1002/ijc.31134. Epub 2017 Nov 6.
8
Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.β-连环蛋白的过表达诱导口腔鳞状细胞癌对顺铂耐药。
Biomed Res Int. 2016;2016:5378567. doi: 10.1155/2016/5378567. Epub 2016 Jul 27.
9
Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44 cells.源自CD44细胞原位异种移植的口腔鳞状细胞癌中癌症干细胞、细胞角蛋白和上皮-间质转化标志物的表达
Pathol Res Pract. 2017 Mar;213(3):235-244. doi: 10.1016/j.prp.2016.12.009. Epub 2016 Dec 23.
10
Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes.建立具有上皮间质转化改变的 5-氟尿嘧啶耐药口腔鳞状细胞癌细胞系。
Int J Oncol. 2014 Apr;44(4):1302-8. doi: 10.3892/ijo.2014.2270. Epub 2014 Jan 21.

引用本文的文献

1
Long non-coding RNA SNHG16 promotes tumor progression and cisplatin resistance in esophageal squamous cell carcinoma via miR-497-5p/HK2 axis.长链非编码RNA SNHG16通过miR-497-5p/HK2轴促进食管鳞状细胞癌的肿瘤进展和顺铂耐药。
J Cardiothorac Surg. 2025 Jul 14;20(1):298. doi: 10.1186/s13019-025-03528-1.
2
The Possibility of Plasma Membrane Transporters as Drug Targets in Oral Cancers.质膜转运蛋白作为口腔癌药物靶点的可能性
Int J Mol Sci. 2025 May 1;26(9):4310. doi: 10.3390/ijms26094310.
3
Extracellular vesicles in liquid biopsies: there is hope for oral squamous cell carcinoma.

本文引用的文献

1
Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer.细胞核C-MYC表达水平与前列腺癌的疾病进展相关,并可能预测其两年总生存率。
Int J Clin Exp Pathol. 2015 Feb 1;8(2):1878-88. eCollection 2015.
2
Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment.癌症相关成纤维细胞中微小RNA-149的表观遗传沉默介导肿瘤微环境中的前列腺素E2/白细胞介素-6信号传导。
Cell Res. 2015 May;25(5):588-603. doi: 10.1038/cr.2015.51. Epub 2015 Apr 28.
3
Prognostic role of Oct4, CD44 and c-Myc in radio-chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice.
液体活检中的细胞外囊泡:口腔鳞状细胞癌有了希望。
Extracell Vesicles Circ Nucl Acids. 2024 Dec 7;5(4):639-659. doi: 10.20517/evcna.2024.29. eCollection 2024.
4
miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting.miR-128-3p 通过靶向 MAP2K7 抑制舌鳞状细胞癌的肿瘤生长并增强化疗敏感性。
Mol Biol Rep. 2024 Oct 30;51(1):1107. doi: 10.1007/s11033-024-10040-7.
5
HNCDrugResDb: a platform for deciphering drug resistance in head and neck cancers.HNCDrugResDb:一个用于解析头颈部癌症耐药性的平台。
Sci Rep. 2024 Oct 25;14(1):25327. doi: 10.1038/s41598-024-75861-9.
6
The Influence of Removable Complete Denture on Pro-Oxidant Antioxidant Balance and Redox-Sensitive Inflammation Biomarker NF-ĸB in the Oral Cavity: An Interventional Follow-Up Study.可摘局部义齿对口腔内促氧化剂/抗氧化剂平衡和氧化还原敏感炎症生物标志物 NF-κB 的影响:一项干预性随访研究。
Clin Exp Dent Res. 2024 Oct;10(5):e70007. doi: 10.1002/cre2.70007.
7
Defects of mitochondria-lysosomes communication induce secretion of mitochondria-derived vesicles and drive chemoresistance in ovarian cancer cells.线粒体-溶酶体通讯缺陷诱导线粒体衍生小泡的分泌并驱动卵巢癌细胞的化疗耐药性。
Cell Commun Signal. 2024 Mar 6;22(1):165. doi: 10.1186/s12964-024-01507-y.
8
A Prognostic Model Based on Cisplatin-Resistance Related Genes in Oral Squamous Cell Carcinoma.基于顺铂耐药相关基因的口腔鳞状细胞癌预后模型。
Oral Health Prev Dent. 2024 Jan 15;22:39-50. doi: 10.3290/j.ohpd.b4836127.
9
Extracellular Vesicle-Based Drug Delivery Systems for Head and Neck Squamous Cell Carcinoma: A Systematic Review.用于头颈部鳞状细胞癌的细胞外囊泡药物递送系统:一项系统综述
Pharmaceutics. 2023 Apr 24;15(5):1327. doi: 10.3390/pharmaceutics15051327.
10
Phosphorylation of IWS1 by AKT maintains liposarcoma tumor heterogeneity through preservation of cancer stem cell phenotypes and mesenchymal-epithelial plasticity.AKT介导的IWS1磷酸化通过维持癌症干细胞表型和间充质-上皮可塑性来保持脂肪肉瘤的肿瘤异质性。
Oncogenesis. 2023 May 26;12(1):30. doi: 10.1038/s41389-023-00469-z.
Oct4、CD44和c-Myc在放化疗耐药口腔癌患者中的预后作用及其在免疫缺陷小鼠中的致瘤潜力。
Clin Oral Investig. 2016 Jan;20(1):43-56. doi: 10.1007/s00784-015-1476-6. Epub 2015 Apr 28.
4
Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.通过整合转录组分析鉴定胰腺癌中的miRNA-mRNA相互作用
Eur Rev Med Pharmacol Sci. 2015;19(5):825-34.
5
MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1.微小RNA-149通过直接靶向叉头框转录因子FOXM1抑制结肠癌细胞的迁移和侵袭。
Cell Physiol Biochem. 2015;35(2):499-515. doi: 10.1159/000369715. Epub 2015 Jan 16.
6
Reduced E-Cadherin expression is a prognostic biomarker of non-small cell lung cancer: a meta-analysis based on 2395 subjects.E-钙黏蛋白表达降低是非小细胞肺癌的一种预后生物标志物:一项基于2395名受试者的荟萃分析。
Int J Clin Exp Med. 2014 Nov 15;7(11):4352-6. eCollection 2014.
7
OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer.OCT4表达和血管生成拟态形成与人类乳腺癌的不良预后呈正相关。
Int J Mol Sci. 2014 Oct 28;15(11):19634-49. doi: 10.3390/ijms151119634.
8
MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic mesenchymal characteristics through the RNA-binding protein AUF1 targeting the transcription factor ZEB1 and the protein kinase AKT.微小 RNA-141 和微小 RNA-146b-5p 通过 RNA 结合蛋白 AUF1 靶向转录因子 ZEB1 和蛋白激酶 AKT 抑制促转移的间充质特征。
J Biol Chem. 2014 Nov 7;289(45):31433-47. doi: 10.1074/jbc.M114.593004. Epub 2014 Sep 26.
9
Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone.miR-146b-5p 和 miR-320d 低表达预示着接受环磷酰胺、多柔比星、长春新碱和泼尼松治疗的大 B 细胞淋巴瘤预后不良。
Hum Pathol. 2014 Aug;45(8):1664-73. doi: 10.1016/j.humpath.2014.04.002. Epub 2014 Apr 18.
10
Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion.循环细胞外 miR-134、miR-185 和 miR-22 水平在肺腺癌相关恶性胸腔积液中的诊断价值。
Cancer Res Treat. 2014 Apr;46(2):178-85. doi: 10.4143/crt.2014.46.2.178. Epub 2014 Apr 22.